Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)

DRUG2 trials

Sponsors

National Taiwan University Hospital

Conditions

Helicobacter Pylori Infection

Phase 4

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection

CompletedNCT02483715

National Taiwan University HospitalHelicobacter Pylori Infection

Start: 2015-07-31End: 2018-05-31Updated: 2019-03-26

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection

CompletedNCT02490839

National Taiwan University HospitalHelicobacter Pylori Infection

Start: 2015-07-31End: 2019-01-31Updated: 2020-04-29